Stem cell startup Aldagen raising $10 million, refiles plans for IPO
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
DURHAM, N.C. - Life-sciences startup Aldagen has refilled plans for an initial public offering of stock just over a year after withdrawing such plans.
The company also is raising financing through debt and warrants, according to a filing with the SEC. Aldagen is seeking to raise $10 million and has so far sold $7.3 million.
For the IPO, Aldagen seeks to raise $80.5 million and trade its stock on the Nasdaq under the symbol “ALDH.” Aldagen did not set a target price for the stock in the filing.
The company has several potential drugs under clinical development. It is focused on adult stem cells.
Backed by regional venture capital firms Intersouth Partners, Aurora Funds and Trelys Funds along with Harbert Venture Partners and Tullis Dickerson, Aldagen closed on $18.4 million in venture financing in April of last year..
Aldagen, which was launched under the name Stemco, has raised some $65 million in venture capital.
Its most advanced product, ADL-101, is in Phase III clinical trial. It could be a treatment for inherited metabolic diseases in pediatric patients. The hope is to improve umbilical cord blood transplants. Aldagen is using umbilical cord blood.
A Phase III trial is being prepared for ALD-301, a potential treatment of critical limb ischemia.
Another, ALD-201, targets ischemic heart failure.
Aldagen utilizes proprietary technology that isolates stem cells that have high levels of the enzyme ALDH which could promote new growth of cells and tissues.
Copyright 2012 WRAL Tech Wire. All rights reserved.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
The Skinny
- Epic Games' Tim Sweeney reaps arts Hall of Fame honor today
- Charlotte's startup efforts pick up steam as more data pours in
- 'Battle in Bay 7' returns - Are you techies ready for some basketball?
- Inside RTP's new angel fund: Founders meeting 'significant' need
- Who won 'Social Bowl'? Super Bowl ads paying fans to play
- RTP broadband firm Overture, minus two top execs, launches new look
- Will RTP-based ChannelAdvisor go public? They're thinking
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised


